Vivani Medical, Inc. · NASDAQ:VANI

Vivani Medical, Inc. financial statements

Vivani Medical, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue00002601.00K3.38M6.90M7.96M4.00M
Cost of revenue424.0K400.0K357.0K381.0K130.0K500.0K2.15M4.89M5.12M10.1M
Gross profit-424.0K-400.0K-357.0K-381.0K130.0K500.0K1.23M2.01M2.85M-6.09M
Research and development18.1M15.7M17.0M14.2M11.0M4.84M13.1M10.0M7.89M5.35M
Selling, general and administrative9.43M8.93M10.00M5.37M2.32M2.38M9.23M10.7M10.9M10.1M
Operating income-27.6M-24.7M-27.0M-21.2M-13.3M-14.9M-34.0M-35.2M-28.6M-33.2M
Depreciation and amortization424.0K400.0K357.0K381.0K345.0K164.0K397.0K435.0K457.0K432.0K
EBITDA-27.1M-24.3M-26.6M-20.9M-13.0M-14.7M-33.6M-34.7M-28.2M-32.8M
Interest expense7.35M550.0K000
Income before tax-26.6M-23.5M-25.7M-13.9M-12.8M-9.28M-33.6M-35.1M-28.5M-33.2M
Income tax2.00K-7.35M-641.0K147.7K0093.0K31.0K
Net income-26.6M-23.5M-25.7M-13.9M-12.8M-14.9M-33.6M-35.1M-28.5M-33.2M
Earnings per share, basic-0.43-0.43-0.50-273.75-0.27-0.72-2.28-4.23-0.53-0.84
Earnings per share, diluted-0.43-0.43-0.50-0.27-0.72-2.28-4.23-0.53-0.84

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents16.2M18.4M20.7M45.1M2.18M2.08M11.3M4.47M7.84M10.9M
Short-term investments7.24M10.3M
Receivables654.0K253.0K455.0K504.0K1.83M274.0K
Inventory1.03M3.25M2.70M3.42M
Current assets17.9M20.4M23.1M47.5M2.47M4.27M13.1M9.62M13.2M15.3M
Property, plant and equipment2.88M1.69M1.73M1.18M1.17M174.0K1.12M1.02M1.30M1.49M
Total assets39.4M41.6M45.8M51.1M5.45M4.46M16.6M10.7M14.5M16.8M
Accounts payable1.03M817.0K542.0K1.18M281.0K486.0K1.09M1.30M752.0K1.16M
Current liabilities6.60M5.99M5.72M6.82M2.09M5.13M6.96M7.60M6.62M5.66M
Total debt18.9M19.3M20.7M955.0K1.81M2.47M2.60M
Total liabilities23.7M24.0M25.0M6.82M2.99M5.13M9.32M7.60M6.62M5.66M
Shareholders' equity15.7M17.6M20.8M44.3M2.46M1.95M7.28M3.08M7.88M11.1M
Shares outstanding76.4M59.2M51.0M50.7K36.8M23.2K15.6M9.54M57.6M42.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-24.3M-20.8M-23.7M-18.8M-11.0M-16.8M-27.6M-29.8M-23.9M-25.1M
Capital spending-1.17M-556.0K-887.0K-338.0K-572.0K-330.0K-493.0K-163.0K-265.0K-490.0K
Free cash flow-25.5M-21.3M-24.6M-19.1M-11.5M-17.2M-28.1M-30.0M-24.2M-25.6M
Cash from investing-1.17M-556.0K-887.0K-338.0K-572.0K68.0K-493.0K-163.0K-265.0K-490.0K
Cash from financing23.3M19.1M133.0K63.4M11.6M8.60M35.0M26.6M21.2M20.5M
Share buybacks-28.0K-281.0K
Change in cash-2.12M-2.30M-24.4M44.3M97.0K-8.15M6.86M-3.37M-3.04M-5.08M